|
US5744347A
(en)
*
|
1987-01-16 |
1998-04-28 |
Ohio University Edison Biotechnology Institute |
Yolk sac stem cells and their uses
|
|
US5763266A
(en)
*
|
1989-06-15 |
1998-06-09 |
The Regents Of The University Of Michigan |
Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
|
|
US5399493A
(en)
*
|
1989-06-15 |
1995-03-21 |
The Regents Of The University Of Michigan |
Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
|
|
US5635386A
(en)
*
|
1989-06-15 |
1997-06-03 |
The Regents Of The University Of Michigan |
Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture
|
|
US5605822A
(en)
*
|
1989-06-15 |
1997-02-25 |
The Regents Of The University Of Michigan |
Methods, compositions and devices for growing human hematopoietic cells
|
|
US5061620A
(en)
*
|
1990-03-30 |
1991-10-29 |
Systemix, Inc. |
Human hematopoietic stem cell
|
|
US5635387A
(en)
*
|
1990-04-23 |
1997-06-03 |
Cellpro, Inc. |
Methods and device for culturing human hematopoietic cells and their precursors
|
|
US5622853A
(en)
*
|
1990-05-01 |
1997-04-22 |
Becton Dickinson And Company |
T lymphocyte precursor
|
|
US5840580A
(en)
*
|
1990-05-01 |
1998-11-24 |
Becton Dickinson And Company |
Phenotypic characterization of the hematopoietic stem cell
|
|
US6631842B1
(en)
*
|
2000-06-07 |
2003-10-14 |
Metrologic Instruments, Inc. |
Method of and system for producing images of objects using planar laser illumination beams and image detection arrays
|
|
US5541072A
(en)
*
|
1994-04-18 |
1996-07-30 |
Immunivest Corporation |
Method for magnetic separation featuring magnetic particles in a multi-phase system
|
|
US6010696A
(en)
*
|
1990-11-16 |
2000-01-04 |
Osiris Therapeutics, Inc. |
Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells
|
|
US5340719A
(en)
*
|
1990-11-23 |
1994-08-23 |
Corporation Coulter |
Method and apparatus for optically screening microscopic cells
|
|
US5348859A
(en)
*
|
1990-11-23 |
1994-09-20 |
Coulter Corporation |
Method and apparatus for obtaining an absolute white blood cell subset count and white blood cell multipart differential
|
|
US5464753A
(en)
*
|
1991-03-08 |
1995-11-07 |
Univ Illinois |
Purification and manipulation of bone marrow and blood cells on the basis of P-glycoprotein expression
|
|
US5994088A
(en)
|
1991-03-08 |
1999-11-30 |
Board Of Trustees Of The University Of Illinois |
Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
|
|
US5849686A
(en)
*
|
1991-03-11 |
1998-12-15 |
Creative Biomolecules, Inc. |
Morphogen-induced liver regeneration
|
|
US5795470A
(en)
*
|
1991-03-25 |
1998-08-18 |
Immunivest Corporation |
Magnetic separation apparatus
|
|
US5367057A
(en)
*
|
1991-04-02 |
1994-11-22 |
The Trustees Of Princeton University |
Tyrosine kinase receptor flk-2 and fragments thereof
|
|
US5185438A
(en)
*
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
|
EP0578774B1
(de)
*
|
1991-04-05 |
1998-07-29 |
The Board Of Regents Of The University Of Washington |
Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor
|
|
WO1992018615A1
(en)
*
|
1991-04-09 |
1992-10-29 |
Indiana University Foundation |
System and process for supporting hematopoietic cells
|
|
US5744361A
(en)
*
|
1991-04-09 |
1998-04-28 |
Indiana University |
Expansion of human hematopoietic progenitor cells in a liquid medium
|
|
WO1993003142A1
(en)
*
|
1991-08-07 |
1993-02-18 |
Albert Einstein College Of Medicine |
Proliferation of hepatocyte precursors
|
|
US6069005A
(en)
|
1991-08-07 |
2000-05-30 |
Albert Einstein College Of Medicine Of Yeshwa University |
Hapatoblasts and method of isolating same
|
|
NL9101680A
(nl)
*
|
1991-10-04 |
1993-05-03 |
Tno |
Werkwijze voor het genetisch modificeren van beenmergcellen van primaten, alsmede daarbij bruikbare cellen die recombinante retrovirale vectoren produceren.
|
|
ES2180539T3
(es)
*
|
1991-10-23 |
2003-02-16 |
Nexell Therapeutics Inc |
Metodos para expandir selectivamente celulas madre.
|
|
WO1993007745A1
(en)
*
|
1991-10-23 |
1993-04-29 |
Cellpro, Incorporated |
Method for freezing engrafting cells
|
|
US6353150B1
(en)
*
|
1991-11-22 |
2002-03-05 |
Hsc Research And Development Limited Partnership |
Chimeric mammals with human hematopoietic cells
|
|
WO1993018136A1
(en)
*
|
1992-03-05 |
1993-09-16 |
Cytomed, Inc. |
Process for supporting hematopoietic progenitor cells
|
|
WO1993018648A1
(en)
*
|
1992-03-23 |
1993-09-30 |
Baxter International Inc. |
In vitro-derived human neutrophil precursor cells
|
|
US5888499A
(en)
*
|
1992-03-23 |
1999-03-30 |
Nexell Therapeutics Inc. |
Method for increasing neutrophil populations using in vitro-derived human neutrophil precursor cells
|
|
US5436151A
(en)
*
|
1992-04-03 |
1995-07-25 |
Regents Of The University Of Minnesota |
Method for culturing human hematopoietic stem cells in vitro
|
|
US5460964A
(en)
*
|
1992-04-03 |
1995-10-24 |
Regents Of The University Of Minnesota |
Method for culturing hematopoietic cells
|
|
IL106295A
(en)
*
|
1992-07-10 |
2001-03-19 |
Univ Pittsburgh |
Hematopoietic facilitaroy cells
|
|
SG55145A1
(en)
*
|
1992-07-10 |
1998-12-21 |
Univ Pittsburgh |
Hematopoietic facilitatory cells and their uses
|
|
US5654183A
(en)
*
|
1992-07-27 |
1997-08-05 |
California Institute Of Technology |
Genetically engineered mammalian neural crest stem cells
|
|
NZ256154A
(en)
*
|
1992-07-27 |
1997-02-24 |
California Inst Of Techn |
Production of mammalian multipotent neural stem cells, antibodies
|
|
US5849553A
(en)
*
|
1992-07-27 |
1998-12-15 |
California Institute Of Technology |
Mammalian multipotent neural stem cells
|
|
US5672499A
(en)
*
|
1992-07-27 |
1997-09-30 |
California Institute Of Technology |
Immoralized neural crest stem cells and methods of making
|
|
US5589376A
(en)
*
|
1992-07-27 |
1996-12-31 |
California Institute Of Technology |
Mammalian neural crest stem cells
|
|
WO1994002016A1
(en)
*
|
1992-07-28 |
1994-02-03 |
Steven Kessler |
Methods for positive immunoselection of stem cells
|
|
CA2080255A1
(en)
*
|
1992-07-31 |
1994-02-01 |
Connie J. Eaves |
Primitive hematopoietic stem cell preparations
|
|
US5466572A
(en)
*
|
1992-09-03 |
1995-11-14 |
Systemix, Inc. |
High speed flow cytometric separation of viable cells
|
|
AU681597B2
(en)
*
|
1992-09-03 |
1997-09-04 |
Regents Of The University Of California, The |
High speed flow cytometric separation of viable mammalian cells
|
|
US5342776A
(en)
*
|
1992-09-04 |
1994-08-30 |
Bolnet Marie C N |
Avian hemopoietic progenitor cells
|
|
WO1994008039A1
(en)
*
|
1992-10-02 |
1994-04-14 |
Systemix, Inc. |
Method of enrichment for human hematopoietic stem cells using c-kit
|
|
US5766951A
(en)
*
|
1992-11-12 |
1998-06-16 |
Quality Biological, Inc. |
Serum-free medium supporting growth and proliferation of normal bone marrow cells
|
|
DE69309487T2
(de)
*
|
1992-11-13 |
1997-10-23 |
Univ Washington |
Peripheralisierung hämatopoietischer stammzellen
|
|
JPH08506007A
(ja)
*
|
1992-11-16 |
1996-07-02 |
アプライド イミューン サイエンシーズ，インコーポレイテッド |
多能性の休止状態の幹細胞集団
|
|
US5409710A
(en)
*
|
1993-04-20 |
1995-04-25 |
Endocon, Inc. |
Foam cell drug delivery
|
|
JPH08509720A
(ja)
*
|
1993-05-03 |
1996-10-15 |
ジェネンテク、インコーポレイテッド |
白血球接着阻害
|
|
US6060049A
(en)
*
|
1993-05-24 |
2000-05-09 |
Ximerex, Inc. |
Surrogate tolerogenesis for the development of tolerance to xenografts
|
|
US5554512A
(en)
*
|
1993-05-24 |
1996-09-10 |
Immunex Corporation |
Ligands for flt3 receptors
|
|
CZ307995A3
(en)
|
1993-05-24 |
1996-10-16 |
Immunex Corp |
Ligands for flt3 receptors
|
|
US5772994A
(en)
*
|
1993-05-28 |
1998-06-30 |
The University Of Pittsburgh |
Hematopoietic facilitatory cells and their uses
|
|
US6033906A
(en)
*
|
1993-07-26 |
2000-03-07 |
California Institute Of Technology |
Methods for differentiating neural stem cells to glial cells using neuregulins
|
|
AU7476694A
(en)
*
|
1993-07-29 |
1995-02-28 |
Systemix, Inc. |
Novel stem cell marker
|
|
CA2170357A1
(en)
*
|
1993-08-25 |
1995-03-02 |
David Digiusto |
Method for producing a highly enriched population of hematopoietic stem cells
|
|
AU7832394A
(en)
*
|
1993-09-08 |
1995-03-27 |
Imclone Systems Incorporated |
Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
|
|
WO1995008105A1
(en)
*
|
1993-09-17 |
1995-03-23 |
Systemix, Inc. |
Method for obtaining a cell population enriched in stem cells and compositions derived therefrom
|
|
US5409813A
(en)
*
|
1993-09-30 |
1995-04-25 |
Systemix, Inc. |
Method for mammalian cell separation from a mixture of cell populations
|
|
US5599703A
(en)
*
|
1993-10-28 |
1997-02-04 |
The United States Of America As Represented By The Secretary Of The Navy |
In vitro amplification/expansion of CD34+ stem and progenitor cells
|
|
US6190655B1
(en)
|
1993-12-03 |
2001-02-20 |
Immunex Corporation |
Methods of using Flt-3 ligand for exogenous gene transfer
|
|
SG54291A1
(en)
*
|
1994-01-05 |
1998-11-16 |
Univ Pittsburgh |
Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells
|
|
US6001654A
(en)
*
|
1994-01-28 |
1999-12-14 |
California Institute Of Technology |
Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors
|
|
US20030108545A1
(en)
*
|
1994-02-10 |
2003-06-12 |
Patricia Rockwell |
Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist
|
|
US6448077B1
(en)
*
|
1994-02-10 |
2002-09-10 |
Imclone Systems, Inc. |
Chimeric and humanized monoclonal antibodies specific to VEGF receptors
|
|
US7294331B2
(en)
*
|
1994-03-07 |
2007-11-13 |
Immunex Corporation |
Methods of using flt3-ligand in hematopoietic cell transplantation
|
|
US6242417B1
(en)
|
1994-03-08 |
2001-06-05 |
Somatogen, Inc. |
Stabilized compositions containing hemoglobin
|
|
US5631219A
(en)
*
|
1994-03-08 |
1997-05-20 |
Somatogen, Inc. |
Method of stimulating hematopoiesis with hemoglobin
|
|
US5985660A
(en)
*
|
1994-06-15 |
1999-11-16 |
Systemix, Inc. |
Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
|
|
US5972627A
(en)
*
|
1994-06-15 |
1999-10-26 |
Systemix, Inc. |
Method of purifying a population of cells enriched for dendritic and/or lymphoid progenitors and populations of cells obtained thereby
|
|
DE69530980T2
(de)
*
|
1994-06-15 |
2004-05-19 |
Systemix, Inc., Palo Alto |
Population von mit myeloid-und/oder lymphoid-vorläufern angereicherten zellen und verfahren zur ihrer gewinnung und verwendung
|
|
US5972703A
(en)
|
1994-08-12 |
1999-10-26 |
The Regents Of The University Of Michigan |
Bone precursor cells: compositions and methods
|
|
US5474687A
(en)
*
|
1994-08-31 |
1995-12-12 |
Activated Cell Therapy, Inc. |
Methods for enriching CD34+ human hematopoietic progenitor cells
|
|
US5827742A
(en)
*
|
1994-09-01 |
1998-10-27 |
Beth Israel Deaconess Medical Center, Inc. |
Method of selecting pluripotent hematopioetic progenitor cells
|
|
US5650317A
(en)
*
|
1994-09-16 |
1997-07-22 |
Michigan State University |
Human breast epithelial cell type with stem cell and luminal epithelial cell characteristics
|
|
US6140119A
(en)
*
|
1994-09-16 |
2000-10-31 |
Michigan State University |
Expression of estrogen receptors in type I and type II human breast epithelial cells
|
|
US5686577A
(en)
*
|
1994-10-17 |
1997-11-11 |
Cornell Research Foundation, Inc. |
T cell factors influencing B cell development
|
|
US5677136A
(en)
*
|
1994-11-14 |
1997-10-14 |
Systemix, Inc. |
Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
|
|
US5665557A
(en)
*
|
1994-11-14 |
1997-09-09 |
Systemix, Inc. |
Method of purifying a population of cells enriched for hematopoietic stem cells populations of cells obtained thereby and methods of use thereof
|
|
WO1996015227A1
(en)
*
|
1994-11-14 |
1996-05-23 |
Novartis Ag |
Methods of inducing cell death of primitive hematopoietic cells and compositions for induction thereof
|
|
US5610056A
(en)
*
|
1994-11-16 |
1997-03-11 |
Amgen Inc. |
Use of stem cell factor interleukin-6 and soluble interleukin-6 receptor to induce the development of hematopoietic stem cells
|
|
US5874301A
(en)
*
|
1994-11-21 |
1999-02-23 |
National Jewish Center For Immunology And Respiratory Medicine |
Embryonic cell populations and methods to isolate such populations
|
|
US5665350A
(en)
*
|
1994-11-23 |
1997-09-09 |
University Of Massachusetts Medical Center |
Cell cycle dependent transplantation and ex vivo gene therapy
|
|
WO1996016674A1
(en)
*
|
1994-12-01 |
1996-06-06 |
New England Deaconess Hospital Corporation |
In vitro t-lymphopoiesis system
|
|
US5843780A
(en)
*
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
|
GB9502022D0
(en)
*
|
1995-02-02 |
1995-03-22 |
Abuljadayel Ilham M S |
A method for preparing lymphohaematopoietic progenitor cells
|
|
US9068164B1
(en)
*
|
1995-02-02 |
2015-06-30 |
Tristem Trading (Cyprus) Limited |
Method of preparing an undifferentiated cell
|
|
US5830755A
(en)
*
|
1995-03-27 |
1998-11-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
T-cell receptors and their use in therapeutic and diagnostic methods
|
|
US5876956A
(en)
*
|
1995-05-15 |
1999-03-02 |
Johns Hopkins University School Of Medicine |
Methods for identification or purification of cells containing an enzymatic intracellular marker
|
|
US5674750A
(en)
*
|
1995-05-19 |
1997-10-07 |
T. Breeders |
Continuous selective clonogenic expansion of relatively undifferentiated cells
|
|
US5925567A
(en)
*
|
1995-05-19 |
1999-07-20 |
T. Breeders, Inc. |
Selective expansion of target cell populations
|
|
US5728581A
(en)
*
|
1995-06-07 |
1998-03-17 |
Systemix, Inc. |
Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
|
|
US6015554A
(en)
*
|
1995-06-07 |
2000-01-18 |
Systemix, Inc. |
Method of reconstituting human lymphoid and dendritic cells
|
|
WO1996040875A1
(en)
*
|
1995-06-07 |
1996-12-19 |
Novartis Ag |
Methods for obtaining compositions enriched for hematopoietic stem cells and antibodies for use therein
|
|
US5861313A
(en)
*
|
1995-06-07 |
1999-01-19 |
Ontogeny, Inc. |
Method of isolating bile duct progenitor cells
|
|
US20020182730A1
(en)
*
|
1995-07-26 |
2002-12-05 |
Micheal L. Gruenberg |
Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
|
|
US20020034517A1
(en)
*
|
1995-10-04 |
2002-03-21 |
Kenneth Brasel |
Dendritic cell stimulatory factor
|
|
US7361330B2
(en)
*
|
1995-10-04 |
2008-04-22 |
Immunex Corporation |
Methods of using flt3-ligand in the treatment of fibrosarcoma
|
|
US7150992B1
(en)
|
1995-10-04 |
2006-12-19 |
Innunex Corporation |
Methods of preparing dendritic cells with flt3-ligand and antigen
|
|
US6060052A
(en)
*
|
1995-10-30 |
2000-05-09 |
Systemix, Inc. |
Methods for use of Mpl ligands with primitive human hematopoietic stem cells
|
|
US5910434A
(en)
|
1995-12-15 |
1999-06-08 |
Systemix, Inc. |
Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant
|
|
AU1430997A
(en)
*
|
1995-12-19 |
1997-07-14 |
Systemix, Inc. |
Primate cluster-forming embryonic hematopoietic stem cells
|
|
JP2000503542A
(ja)
*
|
1996-01-16 |
2000-03-28 |
デピュイ オーソピーディック，インコーポレイテッド |
造血及び非造血組織からの前駆細胞の分離及び ｉｎ ｖｉｖｏ 骨及び軟骨再生におけるそれらの使用
|
|
EP0891419A4
(de)
|
1996-03-12 |
2000-03-01 |
Life Technologies Inc |
Nährstoffzusatz für hematopoetische zellkulturen
|
|
US6455678B1
(en)
*
|
1996-04-26 |
2002-09-24 |
Amcell Corporation |
Human hematopoietic stem and progenitor cell antigen
|
|
US5843633A
(en)
*
|
1996-04-26 |
1998-12-01 |
Amcell Corporation |
Characterization of a human hematopoietic progenitor cell antigen
|
|
US5928638A
(en)
*
|
1996-06-17 |
1999-07-27 |
Systemix, Inc. |
Methods for gene transfer
|
|
WO1998001151A1
(en)
*
|
1996-07-10 |
1998-01-15 |
Meiji Milk Products Co., Ltd. |
Novel use of mk family as hematopoietic factor
|
|
CA2262817A1
(en)
*
|
1996-08-19 |
1998-02-26 |
James Robl |
Embryonic or stem-like cell lines produced by cross species nuclear transplantation
|
|
US7696404B2
(en)
*
|
1996-08-19 |
2010-04-13 |
Advanced Cell Technology, Inc. |
Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions
|
|
US5945337A
(en)
|
1996-10-18 |
1999-08-31 |
Quality Biological, Inc. |
Method for culturing CD34+ cells in a serum-free medium
|
|
WO1998021334A2
(en)
|
1996-11-13 |
1998-05-22 |
Morphogenesis, Inc. |
Antibody mg1 recognizing a small subset of human hematopoietic cells
|
|
AU731937B2
(en)
*
|
1996-12-10 |
2001-04-05 |
Hadasit Medical Research Services & Development Company Ltd |
Serum-derived factor inducing cell differentiation and medical uses thereof
|
|
WO1998037240A1
(en)
*
|
1997-02-24 |
1998-08-27 |
Tm Technologies, Inc. |
Anti-sense oligonucleotide pharmacological agents
|
|
US6090622A
(en)
*
|
1997-03-31 |
2000-07-18 |
The Johns Hopkins School Of Medicine |
Human embryonic pluripotent germ cells
|
|
US6331406B1
(en)
|
1997-03-31 |
2001-12-18 |
The John Hopkins University School Of Medicine |
Human enbryonic germ cell and methods of use
|
|
US5948426A
(en)
*
|
1997-05-03 |
1999-09-07 |
Jefferies; Steven R. |
Method and article to induce hematopoietic expansion
|
|
EP1003847A4
(de)
|
1997-09-04 |
2005-04-06 |
Science Res Lab Inc |
Zelltrennung mittels elektrischer felder
|
|
US6440734B1
(en)
*
|
1998-09-25 |
2002-08-27 |
Cytomatrix, Llc |
Methods and devices for the long-term culture of hematopoietic progenitor cells
|
|
US6093531A
(en)
|
1997-09-29 |
2000-07-25 |
Neurospheres Holdings Ltd. |
Generation of hematopoietic cells from multipotent neural stem cells
|
|
US5955257A
(en)
*
|
1997-10-21 |
1999-09-21 |
Regents Of The University Of Minnesota |
Infusible grade short-term cell storage medium for mononuclear cells
|
|
US6734338B1
(en)
|
1997-11-14 |
2004-05-11 |
Cedars-Sinai Medical Center |
Transfection, storage and transfer of male germ cells for generation of transgenic species and genetic therapies
|
|
US7294755B1
(en)
|
1997-11-14 |
2007-11-13 |
Cedars-Sinai Medical Center |
Genetic modification of male germ cells for generation of transgenic species and genetic therapies
|
|
DE69840671D1
(de)
*
|
1997-11-14 |
2009-04-30 |
Cedars Sinai Medical Center |
Transfektion und transfer nicht humaner männlicher keimzellen zur generierung transgener nicht humaner säugetiere
|
|
US6361642B1
(en)
|
1997-12-02 |
2002-03-26 |
Baxter International Inc. |
Heat and pressure-formed flexible containers
|
|
WO1999028486A1
(en)
*
|
1997-12-04 |
1999-06-10 |
Duke University |
Methods of isolating and using cd7+cd34-lin-hematopoietic cells
|
|
US6059968A
(en)
*
|
1998-01-20 |
2000-05-09 |
Baxter International Inc. |
Systems for processing and storing placenta/umbilical cord blood
|
|
US6852533B1
(en)
|
1998-01-23 |
2005-02-08 |
Cornell Research Foundation, Inc. |
Purified populations of stem cells
|
|
US20020034819A1
(en)
*
|
1998-02-23 |
2002-03-21 |
Alan K. Smith |
Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
|
|
EP2019145A1
(de)
|
1998-05-29 |
2009-01-28 |
Case Western Reserve University |
Gentransduktion einer hämopoetischen Vorläuferzelle
|
|
US6451558B1
(en)
*
|
1998-08-03 |
2002-09-17 |
Novartis Ag |
Genes in the control of hematopoiesis
|
|
EP1270719A3
(de)
*
|
1998-08-24 |
2003-06-25 |
Viacell, Inc. |
Hemangioblasten enthaltender Zellverband und dessen Herstellungsverfahren
|
|
WO2000014203A1
(en)
*
|
1998-09-02 |
2000-03-16 |
Chugai Seiyaku Kabushiki Kaisha |
Method for preparing cell fraction containing hematopoietic stem cells
|
|
US8297377B2
(en)
*
|
1998-11-20 |
2012-10-30 |
Vitruvian Exploration, Llc |
Method and system for accessing subterranean deposits from the surface and tools therefor
|
|
DK1975243T3
(da)
*
|
1998-12-07 |
2010-06-28 |
Univ Duke |
BODIPY-aminoacetaldehyddiethylacetal
|
|
US6627191B1
(en)
*
|
1999-01-25 |
2003-09-30 |
Seattle Biomedical Research Institute |
Anti-transforming growth factor Beta (TGF-β) treated stem cell composition and method
|
|
DE60016567T2
(de)
*
|
1999-02-03 |
2005-12-08 |
I.D.M. Immuno-Designed Molecules |
Makrophagenhaltige zusammensetzung mit antiinfektiösen und hematopoietischen eigenschaften sowie deren herstellungsmethode
|
|
US6153113A
(en)
|
1999-02-22 |
2000-11-28 |
Cobe Laboratories, Inc. |
Method for using ligands in particle separation
|
|
US6238922B1
(en)
|
1999-02-26 |
2001-05-29 |
Stemcells, Inc. |
Use of collagenase in the preparation of neural stem cell cultures
|
|
US20040265285A1
(en)
*
|
1999-04-15 |
2004-12-30 |
Monash University |
Normalization of defective T cell responsiveness through manipulation of thymic regeneration
|
|
US20070274946A1
(en)
*
|
1999-04-15 |
2007-11-29 |
Norwood Immunoloty, Ltd. |
Tolerance to Graft Prior to Thymic Reactivation
|
|
AUPR074500A0
(en)
*
|
2000-10-13 |
2000-11-09 |
Monash University |
Treatment of t cell disorders
|
|
US20040259803A1
(en)
*
|
1999-04-15 |
2004-12-23 |
Monash University |
Disease prevention by reactivation of the thymus
|
|
US20040258672A1
(en)
*
|
1999-04-15 |
2004-12-23 |
Monash University |
Graft acceptance through manipulation of thymic regeneration
|
|
US20040241842A1
(en)
*
|
1999-04-15 |
2004-12-02 |
Monash University |
Stimulation of thymus for vaccination development
|
|
US20050020524A1
(en)
*
|
1999-04-15 |
2005-01-27 |
Monash University |
Hematopoietic stem cell gene therapy
|
|
US7759113B2
(en)
*
|
1999-04-30 |
2010-07-20 |
The General Hospital Corporation |
Fabrication of tissue lamina using microfabricated two-dimensional molds
|
|
ATE288478T1
(de)
*
|
1999-04-30 |
2005-02-15 |
Massachusetts Gen Hospital |
Herstellung von dreidimensionalem vaskularisierten gewebe mittels der verwendung von zweidimensionalen mikrohergestellten formen
|
|
JP2003530899A
(ja)
*
|
1999-06-23 |
2003-10-21 |
オレゴン ヘルス アンド サイエンス ユニバーシティー |
造血を増強する方法
|
|
US6821513B1
(en)
|
1999-06-23 |
2004-11-23 |
Oregon Health & Science University |
Method for enhancing hematopoiesis
|
|
US10638734B2
(en)
|
2004-01-05 |
2020-05-05 |
Abt Holding Company |
Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
|
|
US8252280B1
(en)
|
1999-08-05 |
2012-08-28 |
Regents Of The University Of Minnesota |
MAPC generation of muscle
|
|
US7015037B1
(en)
*
|
1999-08-05 |
2006-03-21 |
Regents Of The University Of Minnesota |
Multiponent adult stem cells and methods for isolation
|
|
WO2001011011A2
(en)
|
1999-08-05 |
2001-02-15 |
Mcl Llc |
Multipotent adult stem cells and methods for isolation
|
|
WO2002064748A2
(en)
*
|
2001-02-14 |
2002-08-22 |
Furcht Leo T |
Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
|
|
US7994278B1
(en)
|
1999-08-06 |
2011-08-09 |
Nobel Biosciences Llc |
Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
|
|
US6749850B1
(en)
|
1999-08-18 |
2004-06-15 |
The General Hospital Corporation |
Methods, compositions and kits for promoting recovery from damage to the central nervous system
|
|
AU7719300A
(en)
*
|
1999-09-27 |
2001-04-30 |
Ixion Biotechnology, Inc. |
Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
|
|
CN1423523A
(zh)
*
|
1999-11-17 |
2003-06-11 |
罗切斯特大学 |
来自人体内的免疫系统
|
|
US6790614B1
(en)
|
1999-11-19 |
2004-09-14 |
Novartis Ag |
Selectable cell surface marker genes
|
|
US7112576B1
(en)
|
1999-12-10 |
2006-09-26 |
Regents Of The University Of Minnesota |
Compositions and methods for cryopreservation of peripheral blood lymphocytes
|
|
MXPA02006093A
(es)
*
|
1999-12-20 |
2004-08-23 |
Univ Massachusetts |
Celulas tipo madre o embrionicas producidas por transplante nuclear de especies de cruza.
|
|
JP4800544B2
(ja)
*
|
2000-03-15 |
2011-10-26 |
チルドレンズ メディカル センター コーポレーション |
腫瘍治療用の全身性遺伝子送達運搬体
|
|
US7129326B2
(en)
*
|
2000-04-14 |
2006-10-31 |
Genencor International, Inc. |
Methods for selective targeting
|
|
US20020098524A1
(en)
*
|
2000-04-14 |
2002-07-25 |
Murray Christopher J. |
Methods for selective targeting
|
|
US7776021B2
(en)
*
|
2000-04-28 |
2010-08-17 |
The Charles Stark Draper Laboratory |
Micromachined bilayer unit for filtration of small molecules
|
|
US8491884B2
(en)
|
2000-05-03 |
2013-07-23 |
Oncolytics Biotech Inc. |
Virus clearance of neoplastic cells from mixed cellular compositions
|
|
AR028040A1
(es)
*
|
2000-05-03 |
2003-04-23 |
Oncolytics Biotech Inc |
Remocion de virus de celulas neoplasticas a partir de composiciones celulares mixtas
|
|
AR028039A1
(es)
|
2000-05-03 |
2003-04-23 |
Oncolytics Biotech Inc |
Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas
|
|
US6828145B2
(en)
|
2000-05-10 |
2004-12-07 |
Cedars-Sinai Medical Center |
Method for the isolation of stem cells by immuno-labeling with HLA/MHC gene product marker
|
|
MXPA02012067A
(es)
|
2000-06-05 |
2004-08-19 |
Univ Columbia |
Identificacion y uso de celulas endoteliales precursoras derivadas de medula osea par mejorar la funcion del miocardio despues de dano isquemico.
|
|
FR2810045B1
(fr)
*
|
2000-06-07 |
2004-09-03 |
Assist Publ Hopitaux De Paris |
Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
|
|
US6632620B1
(en)
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
|
US6984522B2
(en)
*
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US8044259B2
(en)
*
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
EP1978090A1
(de)
|
2000-08-09 |
2008-10-08 |
ES Cell International Pte Ltd. |
Pankreatische Vorläuferzellen
|
|
US20060088512A1
(en)
*
|
2001-10-15 |
2006-04-27 |
Monash University |
Treatment of T cell disorders
|
|
US20020151050A1
(en)
*
|
2000-10-30 |
2002-10-17 |
Vacanti Charles A. |
Isolation of spore-like cells from tissues exposed to extreme conditions
|
|
IL155728A0
(en)
*
|
2000-11-22 |
2003-11-23 |
Geron Corp |
Tolerizing allografts of pluripotent stem cells
|
|
US6921665B2
(en)
|
2000-11-27 |
2005-07-26 |
Roslin Institute (Edinburgh) |
Selective antibody targeting of undifferentiated stem cells
|
|
US6576464B2
(en)
*
|
2000-11-27 |
2003-06-10 |
Geron Corporation |
Methods for providing differentiated stem cells
|
|
AU2002219987A1
(en)
*
|
2000-12-01 |
2002-06-11 |
The General Hospital Corporation |
Methods and products for manipulating hematopoietic stem cells
|
|
DK1349918T3
(da)
*
|
2000-12-06 |
2014-11-10 |
Anthrogenesis Corp |
Fremgangsmåde til indsamling af stamceller fra moderkagen
|
|
US20080152629A1
(en)
*
|
2000-12-06 |
2008-06-26 |
James Edinger |
Placental stem cell populations
|
|
US7311905B2
(en)
*
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
|
US20030068792A1
(en)
*
|
2000-12-14 |
2003-04-10 |
Yiyou Chen |
Targeted enzymes
|
|
US20030147874A1
(en)
*
|
2000-12-14 |
2003-08-07 |
Volker Schellenberger |
Targeted enzyme prodrug therapy
|
|
US20080248544A1
(en)
*
|
2000-12-14 |
2008-10-09 |
Murray Christopher J |
Methods And Compositions For Grafting Functional Loops Into A Protein
|
|
US20030049689A1
(en)
*
|
2000-12-14 |
2003-03-13 |
Cynthia Edwards |
Multifunctional polypeptides
|
|
CA2432157A1
(en)
*
|
2000-12-19 |
2002-06-27 |
Insight Strategy And Marketing Ltd. |
The use of ecm degrading enzymes for the improvement of cell transplantation
|
|
AU2002239810A1
(en)
|
2001-01-02 |
2002-07-16 |
The Charles Stark Draper Laboratory, Inc. |
Tissue engineering of three-dimensional vascularized using microfabricated polymer assembly technology
|
|
EP2316919B1
(de)
|
2001-02-14 |
2015-10-07 |
Anthrogenesis Corporation |
Post-partum Säugetier-Plazenta, deren Verwendung und daraus gewonnene Stammzellen
|
|
US7723111B2
(en)
*
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
|
FR2821947B1
(fr)
*
|
2001-03-12 |
2003-05-16 |
Canon Kk |
Procede et dispositif de validation de parametres definissant une image
|
|
CA2442177A1
(en)
*
|
2001-03-29 |
2002-10-10 |
Ixion Biotechnology, Inc. |
Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
|
|
US20030095952A1
(en)
*
|
2001-06-13 |
2003-05-22 |
Krause Diane S. |
Multi-organ engraftment with a single bone marrow-derived stem cell
|
|
JP4493882B2
(ja)
*
|
2001-06-19 |
2010-06-30 |
株式会社カネカ |
抗原およびこの抗原を識別するモノクローナル抗体
|
|
US20040247597A1
(en)
*
|
2001-06-20 |
2004-12-09 |
Peter Carmeliet |
Method of treating atherosclerosis and other inflammatory diseases
|
|
US20050026220A1
(en)
*
|
2001-08-10 |
2005-02-03 |
Shahin Rafii |
Isolation and mobilization of stem cells expressing vegfr-1
|
|
US20030049836A1
(en)
*
|
2001-08-15 |
2003-03-13 |
Phi-Wilson Janette T. |
Cell separation system
|
|
DE10144326B4
(de)
*
|
2001-09-10 |
2005-09-22 |
Siemens Ag |
Verfahren und System zur Überwachung eines Reifenluftdrucks
|
|
US20030134341A1
(en)
*
|
2001-09-19 |
2003-07-17 |
Medcell Biologics, Llc. |
Th1 cell adoptive immunotherapy
|
|
US20030134415A1
(en)
*
|
2001-09-19 |
2003-07-17 |
Gruenberg Micheal L. |
Th1 cell adoptive immunotherapy
|
|
US9969980B2
(en)
*
|
2001-09-21 |
2018-05-15 |
Garnet Biotherapeutics |
Cell populations which co-express CD49c and CD90
|
|
WO2003027247A2
(en)
|
2001-09-24 |
2003-04-03 |
Sangamo Biosciences, Inc. |
Modulation of stem cells using zinc finger proteins
|
|
US20030119080A1
(en)
*
|
2001-10-15 |
2003-06-26 |
Mangano Joseph A. |
Strategies for the identification and isolation of cancer stem cells and non-cancerous stem cells
|
|
US7129034B2
(en)
*
|
2001-10-25 |
2006-10-31 |
Cedars-Sinai Medical Center |
Differentiation of whole bone marrow
|
|
US6759244B2
(en)
|
2001-11-08 |
2004-07-06 |
Art Institute Of New York And New Jersey, Inc. |
Composite blastocysts (CBs) from aggregates of dissociated cells of non-viable pre-embryos
|
|
US7799324B2
(en)
*
|
2001-12-07 |
2010-09-21 |
Geron Corporation |
Using undifferentiated embryonic stem cells to control the immune system
|
|
AU2002364537A1
(en)
*
|
2001-12-07 |
2003-06-23 |
Regents Of The University Of Michigan |
Prospective identification and characterization of breast cancer stem cells
|
|
IL162130A0
(en)
|
2001-12-07 |
2005-11-20 |
Robarts Res Inst |
Hematopoietic cells from human embryonic stem cells
|
|
US20040224403A1
(en)
*
|
2001-12-07 |
2004-11-11 |
Robarts Research Institute |
Reconstituting hematopoietic cell function using human embryonic stem cells
|
|
US7190781B2
(en)
*
|
2002-01-04 |
2007-03-13 |
Telefonaktiebolaget Lm Ericsson (Publ) |
Message transfer part point code mapping method and node
|
|
EP2298346A3
(de)
*
|
2002-03-04 |
2011-11-16 |
Imclone LLC |
KDR-spezifische menschliche Antikörper und ihre Verwendung
|
|
US20030175272A1
(en)
*
|
2002-03-07 |
2003-09-18 |
Medcell Biologics, Inc. |
Re-activated T-cells for adoptive immunotherapy
|
|
US20030199464A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Silviu Itescu |
Regeneration of endogenous myocardial tissue by induction of neovascularization
|
|
US20030215935A1
(en)
*
|
2002-05-14 |
2003-11-20 |
Coon David James |
Apparatus and method for isolating living cells from an encapsulated organ tissue sample
|
|
DK1458853T3
(da)
*
|
2002-05-16 |
2010-04-06 |
Absorber Ab |
Fremgangsmåde til donorspecifik krydsmatchning
|
|
US6943021B2
(en)
*
|
2002-06-07 |
2005-09-13 |
Mattek Corporation |
Three dimensional vaginal tissue model containing immune cells
|
|
DK1512015T3
(da)
|
2002-06-12 |
2009-07-06 |
Genencor Int |
Fremgangsmåder til forbedring af bindingsegenskaber hos et molekyle
|
|
CA2493768A1
(en)
*
|
2002-07-23 |
2004-01-29 |
Nanodiagnostics, Inc. |
Embryonic stem cell markers and uses thereof
|
|
US20110158966A1
(en)
*
|
2002-07-23 |
2011-06-30 |
Judith Seligman |
Stem cells characterized by expression of germline specific genes
|
|
WO2007116408A2
(en)
*
|
2006-04-11 |
2007-10-18 |
Nanodiagnostics Israel Ltd. |
Pluripotent stem cells characterized by expression of germline specific genes
|
|
US7635477B2
(en)
*
|
2002-07-25 |
2009-12-22 |
The General Hospital Corporation |
Parathyroid hormone receptor activation and stem and progenitor cell expansion
|
|
AU2003256839B2
(en)
*
|
2002-07-25 |
2009-10-29 |
The General Hospital Corporation |
Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
|
|
US20040028661A1
(en)
*
|
2002-08-07 |
2004-02-12 |
Bartelmez Stephen H. |
Expansion of cells using thrombopoietin and anti-transforming growth factor-beta
|
|
AU2003249749A1
(en)
*
|
2002-08-09 |
2004-02-25 |
Dr. H. Zech Gmbh |
Method for producing cell lines and organs by means of differentiable cells
|
|
US20050271639A1
(en)
|
2002-08-22 |
2005-12-08 |
Penn Marc S |
Genetically engineered cells for therapeutic applications
|
|
US20040044300A1
(en)
*
|
2002-09-03 |
2004-03-04 |
Donnie Rudd |
Method of replenishing cells damaged by treatment for cancer
|
|
US20040077985A1
(en)
*
|
2002-09-03 |
2004-04-22 |
Donnie Rudd |
Method of replenishing cells damaged by treatment for cancer
|
|
US9969977B2
(en)
*
|
2002-09-20 |
2018-05-15 |
Garnet Biotherapeutics |
Cell populations which co-express CD49c and CD90
|
|
CA2504605C
(en)
|
2002-11-13 |
2016-01-19 |
Thomas Jefferson University |
Treatment of chronic lymphocytic leukemia and prostate cancer with microrna mir15
|
|
WO2004046312A2
(en)
*
|
2002-11-15 |
2004-06-03 |
The Board Of Trustees Of The University Of Illinois |
Methods for in vitro expansion of hematopoietic stem cells
|
|
AU2003298775B2
(en)
|
2002-11-26 |
2008-07-17 |
Anthrogenesis Corporation |
Cytotherapeutics, cytotherapeutic units and methods for treatments using them
|
|
US20040110286A1
(en)
*
|
2002-12-06 |
2004-06-10 |
The John P. Robarts Research Institute |
Method for making hematopoietic cells
|
|
WO2004065616A2
(en)
|
2003-01-16 |
2004-08-05 |
The General Hospital Corporation |
Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications
|
|
WO2004071283A2
(en)
*
|
2003-02-13 |
2004-08-26 |
Anthrogenesis Corporation |
Use of umbilical cord blood to treat individuals having a disease, disorder or condition
|
|
WO2004087885A2
(en)
*
|
2003-03-27 |
2004-10-14 |
Ixion Biotechnology, Inc. |
Method for transdifferentiation of non-pancreatic stem cells to the pancreatic pathway
|
|
WO2005034624A2
(en)
|
2003-05-21 |
2005-04-21 |
The General Hospital Corporation |
Microfabricated compositions and processes for engineering tissues containing multiple cell types
|
|
US20060019256A1
(en)
*
|
2003-06-09 |
2006-01-26 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
EP1702062A2
(de)
*
|
2003-06-11 |
2006-09-20 |
Jan Remmereit |
Kern-umprogrammierung von zellen für die therapeutische verwendung
|
|
US9441244B2
(en)
|
2003-06-30 |
2016-09-13 |
The Regents Of The University Of California |
Mutant adeno-associated virus virions and methods of use thereof
|
|
US20060162014A1
(en)
*
|
2003-07-07 |
2006-07-20 |
Jaffe Eileen K |
Alternate morpheeins of allosteric proteins as a target for the development of bioactive molecules
|
|
US8153410B2
(en)
*
|
2003-07-07 |
2012-04-10 |
Fox Chase Cancer Center |
Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
|
|
AU2004263865B2
(en)
|
2003-08-08 |
2007-05-17 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US20070134796A1
(en)
*
|
2005-07-26 |
2007-06-14 |
Sangamo Biosciences, Inc. |
Targeted integration and expression of exogenous nucleic acid sequences
|
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
|
US7569385B2
(en)
*
|
2003-08-14 |
2009-08-04 |
The Regents Of The University Of California |
Multipotent amniotic fetal stem cells
|
|
GB0321337D0
(en)
*
|
2003-09-11 |
2003-10-15 |
Massone Mobile Advertising Sys |
Method and system for distributing advertisements
|
|
WO2005027841A2
(en)
*
|
2003-09-16 |
2005-03-31 |
University Of North Carolina At Chapel Hill |
Cells, compositions and methods for repressing b cell autoantibody secretion and for treating autoimmune disease
|
|
EP1687411B1
(de)
*
|
2003-09-26 |
2015-05-06 |
The Regents Of The University Of Michigan |
Identifizierung und isolierung hämatopoetischer stammzellen
|
|
US9403908B2
(en)
*
|
2003-09-29 |
2016-08-02 |
The Regents Of The University Of California |
Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration
|
|
WO2005049812A1
(en)
*
|
2003-11-19 |
2005-06-02 |
Australian Stem Cell Centre Limited |
Methods for producing blood products from pluripotent cells in cell culture
|
|
KR20060109979A
(ko)
*
|
2003-12-02 |
2006-10-23 |
셀진 코포레이션 |
혈색소병증 및 빈혈의 치료 및 관리를 위한 방법및 조성물
|
|
US20080279812A1
(en)
*
|
2003-12-05 |
2008-11-13 |
Norwood Immunology, Ltd. |
Disease Prevention and Vaccination Prior to Thymic Reactivation
|
|
CA2560544C
(en)
|
2004-01-16 |
2015-05-19 |
Carnegie Mellon University |
Cellular labeling for nuclear magnetic resonance techniques
|
|
WO2005074633A2
(en)
*
|
2004-02-03 |
2005-08-18 |
The Regents Of The University Of Michigan |
Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
|
|
CA2556018A1
(en)
|
2004-02-11 |
2005-09-09 |
Aldagen, Inc. |
Stem cell populations and methods of use
|
|
JP2007528222A
(ja)
*
|
2004-03-09 |
2007-10-11 |
アブソルバー， アーベー |
内皮前駆細胞およびその使用方法
|
|
WO2005098049A2
(en)
*
|
2004-03-25 |
2005-10-20 |
California Institute Of Technology |
Hybridization chain reaction
|
|
US7622108B2
(en)
*
|
2004-04-23 |
2009-11-24 |
Bioe, Inc. |
Multi-lineage progenitor cells
|
|
US7670596B2
(en)
*
|
2004-04-23 |
2010-03-02 |
Bioe, Inc. |
Multi-lineage progenitor cells
|
|
JP2007536936A
(ja)
|
2004-05-14 |
2007-12-20 |
ベクトン・ディキンソン・アンド・カンパニー |
幹細胞集団および使用方法
|
|
US20080233100A1
(en)
*
|
2004-06-30 |
2008-09-25 |
Yiyou Chen |
Targeted enzymes
|
|
CN1993460A
(zh)
*
|
2004-07-12 |
2007-07-04 |
索林集团意大利有限公司 |
用于培养人细胞的装置和方法
|
|
ATE452987T1
(de)
*
|
2004-09-10 |
2010-01-15 |
Genencor Int |
Verfahren zur erkennung von zielen
|
|
US20110098184A1
(en)
*
|
2004-10-15 |
2011-04-28 |
Day Anthony G |
Competitve differntial screeing
|
|
CN101048426A
(zh)
*
|
2004-10-22 |
2007-10-03 |
金克克国际有限公司 |
分离人抗体
|
|
ZA200704252B
(en)
*
|
2004-10-25 |
2009-09-30 |
Cellerant Therapeutics Inc |
Methods of expanding myeloid cell populations and uses thereof
|
|
WO2006052991A2
(en)
|
2004-11-11 |
2006-05-18 |
The General Hosptial Corporation |
Parathyroid hormone receptor activation and stem and progenitor cell expansion
|
|
CN101102791B
(zh)
*
|
2004-11-18 |
2011-12-14 |
英克隆有限责任公司 |
抗血管内皮生长因子受体-1的抗体
|
|
US20080044400A1
(en)
*
|
2004-12-09 |
2008-02-21 |
Volker Schellenberger |
Targeted enzyme prodrug therapy
|
|
GB0503918D0
(en)
*
|
2005-02-25 |
2005-04-06 |
Erasmus University |
Cell
|
|
US7727721B2
(en)
|
2005-03-08 |
2010-06-01 |
California Institute Of Technology |
Hybridization chain reaction amplification for in situ imaging
|
|
US20060252073A1
(en)
*
|
2005-04-18 |
2006-11-09 |
Regents Of The University Of Michigan |
Compositions and methods for the treatment of cancer
|
|
US20060269527A1
(en)
*
|
2005-05-26 |
2006-11-30 |
Australian Stem Cell Centre Limited |
Isolation of cells from bone
|
|
AU2006259583A1
(en)
*
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US20070099209A1
(en)
*
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
CA2617611A1
(en)
*
|
2005-08-01 |
2007-02-08 |
Nupotential, Llc |
Production of reprogrammed cells with restored potential
|
|
EP1924606A4
(de)
|
2005-08-25 |
2010-01-13 |
Repair Technologies Inc |
Vorrichtungen, zusammensetzungen und verfahren zum schutz und zur reparatur von zellen und gewebe
|
|
WO2008020815A1
(en)
|
2006-08-15 |
2008-02-21 |
Agency For Science, Technology And Research |
Mesenchymal stem cell conditioned medium
|
|
JP2009507918A
(ja)
|
2005-09-12 |
2009-02-26 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
Ｂｃｌ２関連癌の診断及び療法のための組成物及び方法
|
|
US7462485B2
(en)
*
|
2005-10-07 |
2008-12-09 |
Glaser Lawrence F |
Modified erythrocytes and uses thereof
|
|
EP1931806B1
(de)
|
2005-10-07 |
2011-10-05 |
California Institute Of Technology |
Pkr-aktivierung mittels hybridisierungskettenreaktion
|
|
DK1957633T3
(en)
|
2005-10-13 |
2014-03-17 |
Anthrogenesis Corp |
Immunomodulation USING PLACE SPEECH STEM CELLS
|
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
|
CA2628255C
(en)
*
|
2005-10-31 |
2016-04-19 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
CA2628221A1
(en)
|
2005-10-31 |
2007-05-10 |
Oncomed Pharmaceuticals, Inc. |
Anti-frizzled receptor antibodies for treating cancer
|
|
US20110076255A1
(en)
|
2005-11-07 |
2011-03-31 |
Pecora Andrew L |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
|
US8637005B2
(en)
|
2005-11-07 |
2014-01-28 |
Amorcyte, Inc. |
Compositions and methods of vascular injury repair
|
|
EP1951864B1
(de)
*
|
2005-11-07 |
2014-05-07 |
Amorcyte, Inc. |
Zusammensetzungen und verfahren zur reparatur von gefässverletzungen
|
|
US9155762B2
(en)
*
|
2005-12-08 |
2015-10-13 |
University Of Louisville Research Foundation, Inc. |
Uses and isolation of stem cells from bone marrow
|
|
WO2007067280A2
(en)
*
|
2005-12-08 |
2007-06-14 |
University Of Louisville Research Foundation, Inc. |
Very small embryonic-like (vsel) stem cells and methods of isolating and using the same
|
|
CN101389754A
(zh)
|
2005-12-29 |
2009-03-18 |
人类起源公司 |
胎盘干细胞和第二来源干细胞的联合培养
|
|
PT2471904T
(pt)
*
|
2005-12-29 |
2019-02-25 |
Celularity Inc |
População de células estaminais placentárias
|
|
CN101421393B
(zh)
*
|
2006-02-14 |
2013-08-14 |
塞勒兰特治疗公司 |
提高造血干细胞植入的方法和组合物
|
|
JP5649786B2
(ja)
|
2006-03-07 |
2015-01-07 |
ギータ シュロフ |
ヒト胚性幹細胞およびそれらの誘導体を含む組成物、使用方法、ならびに調製方法
|
|
WO2007120911A2
(en)
*
|
2006-04-14 |
2007-10-25 |
Carnegie Mellon University |
Cellular labeling and quantification for nuclear magnetic resonance techniques
|
|
WO2008054509A2
(en)
*
|
2006-04-14 |
2008-05-08 |
Celsense, Inc. |
Methods for assessing cell labeling
|
|
CA2646491A1
(en)
*
|
2006-04-17 |
2007-10-25 |
Bioe, Inc. |
Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
|
|
EP2101724B1
(de)
|
2006-05-11 |
2020-12-02 |
Regenics AS |
Verabreichung von zellextrakten zur verjüngung
|
|
US20080064098A1
(en)
*
|
2006-06-05 |
2008-03-13 |
Cryo-Cell International, Inc. |
Procurement, isolation and cryopreservation of maternal placental cells
|
|
US20080050814A1
(en)
*
|
2006-06-05 |
2008-02-28 |
Cryo-Cell International, Inc. |
Procurement, isolation and cryopreservation of fetal placental cells
|
|
US8785193B2
(en)
|
2006-09-14 |
2014-07-22 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Dissection tool and methods of use
|
|
WO2008036374A2
(en)
*
|
2006-09-21 |
2008-03-27 |
Medistem Laboratories, Inc. |
Allogeneic stem cell transplants in non-conditioned recipients
|
|
CA2700573C
(en)
|
2006-09-26 |
2016-11-22 |
Cedars-Sinai Medical Center |
Cancer stem cell antigen vaccines and methods
|
|
US20090155225A1
(en)
*
|
2006-11-02 |
2009-06-18 |
Mariusz Ratajczak |
Uses and isolation of very small of embryonic-like (vsel) stem cells
|
|
WO2008066658A2
(en)
*
|
2006-11-03 |
2008-06-05 |
The Trustees Of Princeton University |
Engineered cellular pathways for programmed autoregulation of differentiation
|
|
CA2913024A1
(en)
|
2006-11-03 |
2008-05-08 |
Aastrom Biosciences, Inc. |
Mixed cell populations for tissue repair and separation technique for cell processing
|
|
WO2008063675A2
(en)
*
|
2006-11-24 |
2008-05-29 |
Regents Of The University Of Minnesota |
Endodermal progenitor cells
|
|
WO2008070861A2
(en)
*
|
2006-12-07 |
2008-06-12 |
Cellerant Therapeutics Inc. |
Methods and compositions for treating systemic lupus erythematosus
|
|
WO2008086529A2
(en)
*
|
2007-01-11 |
2008-07-17 |
Yale University |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
|
EP2108043A4
(de)
|
2007-01-18 |
2010-04-21 |
Suomen Punainen Risti Veripalv |
Neue verfahren und reagentien zur produktion von zellen
|
|
EP2115460A4
(de)
|
2007-01-18 |
2010-01-13 |
Suomen Punainen Risti Veripalv |
Neues kohlenhydrat aus menschlichen zellen und verfahren zur analyse und modifikation davon
|
|
WO2008092002A2
(en)
*
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
|
AU2008216748A1
(en)
*
|
2007-02-12 |
2008-08-21 |
Anthrogenesis Corporation |
Hepatocytes and chondrocytes from adherent placental stem cells; and CD34+, CD45- placental stem cell-enriched cell populations
|
|
EP3763376A1
(de)
|
2007-02-12 |
2021-01-13 |
Celularity, Inc. |
Behandlung von infektionskrankheiten mithilfe von plazenta-stammzellen
|
|
WO2008106551A2
(en)
|
2007-02-28 |
2008-09-04 |
The Govt. Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health & Human Serv. |
Brachyury polypeptides and methods for use
|
|
WO2008106658A2
(en)
*
|
2007-03-01 |
2008-09-04 |
California Institute Of Technology |
TRIGGERED RNAi
|
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
|
US20100172830A1
(en)
*
|
2007-03-29 |
2010-07-08 |
Cellx Inc. |
Extraembryonic Tissue cells and method of use thereof
|
|
EP2607477B1
(de)
|
2007-05-03 |
2020-09-23 |
The Brigham and Women's Hospital, Inc. |
Multipotente stammzellen und ihre verwendung
|
|
US8574567B2
(en)
*
|
2007-05-03 |
2013-11-05 |
The Brigham And Women's Hospital, Inc. |
Multipotent stem cells and uses thereof
|
|
US8609411B2
(en)
*
|
2007-05-04 |
2013-12-17 |
Whitehead Institute For Biomedical Research |
Ex vivo expansion of human hematopoietic stem cells
|
|
WO2008144562A1
(en)
|
2007-05-16 |
2008-11-27 |
California Institute Of Technology |
A versatile nucleic acid hairpin motif for programming biomolecular self-assembly pathways
|
|
TWM322542U
(en)
*
|
2007-05-23 |
2007-11-21 |
Universal Scient Ind Co Ltd |
Testing machine
|
|
EP2171043B1
(de)
*
|
2007-06-15 |
2015-03-18 |
Garnet BioTherapeutics, Inc |
Behandlung von krankheiten und störungen unter verwendung in vitro kultivierter und expandierter selbsterneuernder koloniebildender zellen
|
|
CA2693678C
(en)
*
|
2007-07-10 |
2017-02-14 |
Carnegie Mellon University |
Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
|
|
CA2693827A1
(en)
*
|
2007-07-25 |
2009-01-29 |
Bioe, Inc. |
Differentiation of multi-lineage progenitor cells to chondrocytes
|
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
|
CA2700613C
(en)
*
|
2007-09-26 |
2022-09-20 |
Celgene Cellular Therapeutics |
Angiogenic cells from human placental perfusate
|
|
NZ599825A
(en)
|
2007-09-28 |
2014-10-31 |
Anthrogenesis Corp |
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
|
|
WO2009058983A2
(en)
*
|
2007-10-30 |
2009-05-07 |
University Of Louisville Research Foundation, Inc. |
Subpopulations of bone marrow-derived adherent stem cells and methods of use therefor
|
|
KR20170116221A
(ko)
*
|
2007-11-07 |
2017-10-18 |
안트로제네시스 코포레이션 |
조산 합병증의 치료에 있어서의 제대혈의 용도
|
|
CN101977932B
(zh)
|
2008-01-31 |
2014-09-03 |
美国政府健康及人类服务部 |
工程化抗体恒定结构域分子
|
|
US8497364B2
(en)
*
|
2008-02-27 |
2013-07-30 |
California Institute Of Technology |
Triggered RNAi
|
|
JP2011514169A
(ja)
|
2008-03-17 |
2011-05-06 |
エージェンシー フォー サイエンス，テクノロジー アンド リサーチ |
幹細胞培養のためのマイクロキャリア
|
|
JP2011515470A
(ja)
|
2008-03-28 |
2011-05-19 |
ステムサイト インコーポレーテッド |
臍帯血細胞を用いた脳損傷の処置
|
|
US20110110863A1
(en)
*
|
2008-05-02 |
2011-05-12 |
Celsense, Inc. |
Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
|
|
CA2723848C
(en)
|
2008-05-09 |
2013-01-08 |
Regenics As |
Method of making salmon egg cytoplasmic extracts and use for increasing collagen production in skin
|
|
CA2724839A1
(en)
*
|
2008-05-21 |
2009-11-26 |
Bioe Llc |
Differentiation of multi-lineage progenitor cells to pancreatic cells
|
|
US20100021904A1
(en)
*
|
2008-05-21 |
2010-01-28 |
Pierce Niles A |
Shielded cross-linking probes
|
|
US20100021901A1
(en)
*
|
2008-05-22 |
2010-01-28 |
Peng Yin |
Compositions and methods for detecting analytes
|
|
US8241854B2
(en)
|
2008-05-22 |
2012-08-14 |
California Institute Of Technology |
Triggered RNAi
|
|
US11291686B2
(en)
|
2008-05-30 |
2022-04-05 |
University Of Louisville Research Foundation, Inc. |
Human facilitating cells
|
|
US8632768B2
(en)
*
|
2008-05-30 |
2014-01-21 |
University Of Louisville Research Foundation, Inc. |
Human facilitating cells
|
|
ES2442024T3
(es)
|
2008-07-15 |
2014-02-07 |
Academia Sinica |
Matrices de glucano sobre portaobjetos de vidrio revestidos con aluminio de tipo PTFE y métodos relacionados
|
|
WO2010021715A1
(en)
|
2008-08-20 |
2010-02-25 |
Anthrogenesis Corporation |
Treatment of stroke using isolated placental cells
|
|
KR20240052847A
(ko)
|
2008-08-20 |
2024-04-23 |
셀룰래리티 인코포레이티드 |
개선된 세포 조성물 및 그의 제조 방법
|
|
CA2734446C
(en)
|
2008-08-22 |
2017-06-20 |
Anthrogenesis Corporation |
Methods and compositions for treatment of bone defects with placental cell populations
|
|
JP2012503206A
(ja)
|
2008-09-22 |
2012-02-02 |
オレゴン ヘルス アンド サイエンス ユニバーシティ |
Ｍｙｃｏｂａｃｔｅｒｉｕｍｔｕｂｅｒｃｕｌｏｓｉｓ感染を検出するための方法
|
|
SG190568A1
(en)
|
2008-09-26 |
2013-06-28 |
Oncomed Pharm Inc |
Frizzled-binding agents and uses thereof
|
|
WO2010045495A2
(en)
|
2008-10-16 |
2010-04-22 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
|
|
AU2009316541B2
(en)
|
2008-11-19 |
2015-08-06 |
Celularity Inc. |
Amnion derived adherent cells
|
|
NZ592839A
(en)
*
|
2008-11-21 |
2012-10-26 |
Anthrogenesis Corp |
Treatment of diseases, disorders or conditions of the lung using placental cells
|
|
RU2497532C2
(ru)
*
|
2008-12-03 |
2013-11-10 |
Эморсайт, Инк. |
Композиции, улучшающие перфузию в области инфаркта и способы восстановления сосудистого повреждения
|
|
JP5734869B2
(ja)
|
2008-12-16 |
2015-06-17 |
オンコノバ・セラピューティックス・インコーポレーテッド |
ヒトにおける細胞毒性物質の有害作用に対する治療レジメンの有効性を決定する方法
|
|
WO2010099472A2
(en)
|
2009-02-27 |
2010-09-02 |
The U.S.A. Of America, As Represented By The Secretary, Department Of Health And Human Services |
Spanx-b polypeptides and their use
|
|
US20100239539A1
(en)
*
|
2009-03-23 |
2010-09-23 |
Sing George L |
Methods for promoting differentiation and differentiation efficiency
|
|
US8586360B2
(en)
|
2009-07-02 |
2013-11-19 |
Anthrogenesis Corporation |
Method of producing erythrocytes without feeder cells
|
|
ES2657737T3
(es)
|
2009-07-15 |
2018-03-06 |
Calimmune Inc. |
Vector dual para la inhibición del virus de la inmunodeficiencia humana
|
|
WO2011011500A1
(en)
|
2009-07-21 |
2011-01-27 |
Abt Holding Company |
Use of stem cells to reduce leukocyte extravasation
|
|
WO2011017315A2
(en)
|
2009-08-03 |
2011-02-10 |
Recombinetics, Inc. |
Methods and compositions for targeted gene modification
|
|
US20110268810A1
(en)
|
2009-11-02 |
2011-11-03 |
Yale University |
Polymeric materials loaded with mutagenic and recombinagenic nucleic acids
|
|
EP2499240A1
(de)
|
2009-11-12 |
2012-09-19 |
Vbi Technologies, LLC |
Subpopulationen von sporenartigen zellen und verwendungen davon
|
|
CN102713629B
(zh)
|
2009-11-20 |
2016-02-24 |
俄勒冈健康科学大学 |
用于检测结核分枝杆菌感染的方法
|
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Ｗｎｔ拮抗劑及治療和篩選方法
|
|
DK3284818T3
(da)
|
2010-01-26 |
2022-06-20 |
Celularity Inc |
Behandling af knoglerelateret kræft ved hjælp af placenta stamceller
|
|
DK2539436T3
(da)
|
2010-02-25 |
2021-10-18 |
Abt Holding Co |
Modulering af makrofagaktivering
|
|
CA2794674A1
(en)
|
2010-04-01 |
2011-10-06 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
|
LT2556145T
(lt)
|
2010-04-07 |
2016-11-10 |
Anthrogenesis Corporation |
Angiogenezė naudojant placentos kamienines ląsteles
|
|
MX2012011543A
(es)
|
2010-04-08 |
2013-05-06 |
Anthrogenesis Corp |
Tratamiento de sarcoidosis empleando celulas madre placentarias.
|
|
US9746459B2
(en)
|
2010-04-08 |
2017-08-29 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Antigen presenting cell assay
|
|
EP2556377B1
(de)
|
2010-04-08 |
2017-07-12 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Zellenassay mit b-zellen-antigenen
|
|
US10338069B2
(en)
|
2010-04-12 |
2019-07-02 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
|
US20110262406A1
(en)
|
2010-04-21 |
2011-10-27 |
Yale University |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
|
US20110293585A1
(en)
|
2010-04-21 |
2011-12-01 |
Helix Therapeutics, Inc. |
Compositions and methods for treatment of lysosomal storage disorders
|
|
JP5841322B2
(ja)
|
2010-04-22 |
2016-01-13 |
オレゴン ヘルス アンド サイエンス ユニバーシティ |
フマリルアセト酢酸ヒドロラーゼ（ｆａｈ）欠損性ブタおよびその使用
|
|
US8993532B2
(en)
|
2010-04-23 |
2015-03-31 |
Cold Spring Harbor Laboratory |
Structurally designed shRNAs
|
|
EP2566583B1
(de)
|
2010-05-06 |
2018-07-11 |
Regenics AS |
Verfahren zur Vorbereitung eines Fischeizellextrakts
|
|
US8658780B2
(en)
|
2010-05-18 |
2014-02-25 |
California Institute Of Technology |
Triggered covalent probes for imaging and silencing genetic expression
|
|
EP2582793B1
(de)
|
2010-06-15 |
2017-09-06 |
Cellular Dynamics International, Inc. |
Kompendium aus fertig gebauten stammzellmodellen zur abfrage biologischer reaktionen
|
|
EP2582727B8
(de)
|
2010-06-16 |
2017-04-19 |
University of Pittsburgh- Of the Commonwealth System of Higher Education |
Antikörper zu endoplasmin und deren verwendung
|
|
WO2012006440A2
(en)
|
2010-07-07 |
2012-01-12 |
Cellular Dynamics International, Inc. |
Endothelial cell production by programming
|
|
ES2666746T3
(es)
|
2010-07-13 |
2018-05-07 |
Anthrogenesis Corporation |
Métodos para generar linfocitos citolíticos naturales
|
|
US8877438B2
(en)
|
2010-07-20 |
2014-11-04 |
California Institute Of Technology |
Self-assembled polynucleotide structure
|
|
US8962241B2
(en)
|
2010-07-20 |
2015-02-24 |
California Institute Of Technology |
Triggered molecular geometry based bioimaging probes
|
|
US9834439B2
(en)
|
2010-07-20 |
2017-12-05 |
California Institute Of Technology |
Biomolecular self-assembly
|
|
ES2654994T3
(es)
|
2010-08-12 |
2018-02-15 |
Fate Therapeutics, Inc. |
Terapia mejorada con células madre y precursoras hematopoyéticas
|
|
WO2012048276A2
(en)
|
2010-10-08 |
2012-04-12 |
Caridianbct, Inc. |
Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
|
|
US8574899B2
(en)
|
2010-12-22 |
2013-11-05 |
Vladimir B Serikov |
Methods for augmentation collection of placental hematopoietic stem cells and uses thereof
|
|
JP2014504503A
(ja)
|
2010-12-28 |
2014-02-24 |
ゾーマ テクノロジー リミテッド |
Ｐｄｚドメインを用いた細胞表面提示
|
|
US8969315B2
(en)
|
2010-12-31 |
2015-03-03 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
|
CA2826386C
(en)
|
2011-02-08 |
2020-04-28 |
FUJIFILM Cellular Dynamics, Inc. |
Hematopoietic precursor cell production by programming
|
|
US9150644B2
(en)
|
2011-04-12 |
2015-10-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
|
|
EP2699603B1
(de)
|
2011-04-19 |
2016-03-02 |
The United States of America As Represented by the Secretary Department of Health and Human Services |
Für glypican-3 spezifische humane monoklonale antikörper und ihre verwendung
|
|
JP6104896B2
(ja)
|
2011-06-01 |
2017-03-29 |
アントフロゲネシス コーポレーション |
胎盤幹細胞を使用する疼痛の治療
|
|
PL2718416T3
(pl)
|
2011-06-06 |
2020-05-18 |
ReGenesys BVBA |
Namnażanie komórek macierzystych w bioreaktorach włóknisto-kapilarnych
|
|
KR20150029756A
(ko)
|
2011-06-10 |
2015-03-18 |
블루버드 바이오, 인코포레이티드. |
부신백질이영양증 및 부신척수신경병증을 위한 유전자 요법 벡터
|
|
JP6214530B2
(ja)
|
2011-07-15 |
2017-10-18 |
ザ ジェネラル ホスピタル コーポレイション |
転写活性化因子様エフェクターの組立て方法
|
|
EP2747551B1
(de)
|
2011-08-26 |
2020-02-12 |
Yecuris Corporation |
Fumarylacetoacetat-hydrolase (fah)-defiziente und immundefiziente ratten sowie ihre verwendung
|
|
WO2013055476A1
(en)
|
2011-09-09 |
2013-04-18 |
Anthrogenesis Corporation |
Treatment of amyotrophic lateral sclerosis using placental stem cells
|
|
KR101931403B1
(ko)
|
2011-09-23 |
2018-12-21 |
블루버드 바이오, 인코포레이티드. |
개선된 유전자 치료 방법
|
|
ES2769270T3
(es)
|
2011-09-30 |
2020-06-25 |
Bluebird Bio Inc |
Compuestos para transducción viral mejorada
|
|
EP2785350B1
(de)
|
2011-12-02 |
2018-05-02 |
Fate Therapeutics, Inc. |
Verbesserte verfahren zur behandlung von ischämie
|
|
JP6220791B2
(ja)
|
2011-12-02 |
2017-10-25 |
フェイト セラピューティクス，インコーポレイテッド |
増強された幹細胞組成物
|
|
TWI443107B
(zh)
|
2011-12-29 |
2014-07-01 |
Ind Tech Res Inst |
人源化之抗人類細胞表面抗原ｃｄ３４之單株抗體及其應用
|
|
EP2825557B1
(de)
|
2012-03-16 |
2017-06-28 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Manipuliertes lösliches monomeres fc
|
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
|
SG11201407972RA
(en)
|
2012-06-01 |
2015-01-29 |
Us Health |
High-affinity monoclonal antibodies to glypican-3 and use thereof
|
|
EP2879682B1
(de)
|
2012-08-01 |
2018-03-21 |
United Therapeutics Corporation |
Behandlung von pulmonal-arteriellem hochdruck mit mesenchymalen stammzellen
|
|
ES2713988T3
(es)
|
2012-08-01 |
2019-05-24 |
United Therapeutics Corp |
Tratamiento de hipertensión arterial pulmonar con células progenitoras endoteliales tratadas con prostaciclina
|
|
WO2014031498A1
(en)
|
2012-08-18 |
2014-02-27 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
|
EP3327037B1
(de)
|
2012-08-21 |
2019-10-09 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Domänenspezifische monoklonale mesothelin-antikörper und verwendung davon
|
|
CN104955845B
(zh)
|
2012-09-27 |
2018-11-16 |
美国政府(由卫生和人类服务部的部长所代表) |
间皮素抗体和引起有效的抗肿瘤活性的方法
|
|
AU2013334790A1
(en)
|
2012-10-23 |
2015-04-30 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using Wnt pathway-binding agents
|
|
CN109554350B
(zh)
|
2012-11-27 |
2022-09-23 |
儿童医疗中心有限公司 |
用于胎儿血红蛋白再诱导的靶向bcl11a远端调控元件
|
|
EP3459522B1
(de)
|
2012-12-10 |
2021-02-17 |
Regenics AS |
Verwendung von zellextrakten zur wundbehandlung
|
|
EP2943069B1
(de)
|
2013-01-09 |
2018-08-15 |
United Therapeutics Corporation |
Behandlung von vaskulopathie mit prostacyclin und mesenchymalen stammzellen
|
|
CN105051061B
(zh)
|
2013-01-30 |
2020-02-21 |
康奈尔大学 |
用于扩增干细胞的组合物和方法
|
|
AU2014212081A1
(en)
|
2013-02-04 |
2015-08-13 |
Oncomed Pharmaceuticals, Inc. |
Methods and monitoring of treatment with a Wnt pathway inhibitor
|
|
CN115137753A
(zh)
|
2013-02-05 |
2022-10-04 |
细胞结构公司 |
来自胎盘的自然杀伤细胞
|
|
CN105229144A
(zh)
|
2013-02-22 |
2016-01-06 |
细胞动力学国际有限公司 |
通过组合的遗传工程和化学工程经由正向编程产生肝细胞
|
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
|
WO2014150602A1
(en)
|
2013-03-15 |
2014-09-25 |
Fate Therapeutics, Inc. |
Cell potency assay for therapeutic potential
|
|
US9943545B2
(en)
|
2013-03-15 |
2018-04-17 |
Fate Therapeutics, Inc. |
Stem cell culture media and methods of enhancing cell survival
|
|
AU2014248167B2
(en)
|
2013-04-03 |
2019-10-10 |
FUJIFILM Cellular Dynamics, Inc. |
Methods and compositions for culturing endoderm progenitor cells in suspension
|
|
IL289870B2
(en)
|
2013-04-12 |
2023-03-01 |
Lafrancesca Saverio |
Improving organs for transplantation
|
|
AU2014266935B2
(en)
|
2013-04-30 |
2020-06-11 |
Katholieke Universiteit Leuven |
Cell therapy for myelodysplastic syndromes
|
|
US9758763B2
(en)
|
2013-05-29 |
2017-09-12 |
The Regents Of The University Of California |
Methods and compositions for somatic cell proliferation and viability
|
|
EP3013365B1
(de)
|
2013-06-26 |
2019-06-05 |
Academia Sinica |
Rm2-antigene und verwendung davon
|
|
EP3013347B1
(de)
|
2013-06-27 |
2019-12-11 |
Academia Sinica |
Glykankonjugate und verwendung davon
|
|
US9856472B2
(en)
|
2013-07-01 |
2018-01-02 |
California Institute Of Technology |
Small conditional RNAs
|
|
JP6486368B2
(ja)
|
2013-09-06 |
2019-03-20 |
アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ |
改変されたグリコシル基を含む糖脂質を用いたヒトｉＮＫＴ細胞の活性化
|
|
BR112015032713B1
(pt)
|
2013-09-17 |
2023-03-21 |
Obi Pharma, Inc |
Composto, composição farmacêutica, uso de uma quantidade terapeuticamente efetiva da composição farmacêutica, e uso do composto
|
|
AU2014342811B2
(en)
|
2013-10-15 |
2019-01-03 |
Board Of Regents Of The University Of Texas System |
Compositions and methods of modulating short-chain dehydrogenase activity
|
|
WO2015073913A1
(en)
|
2013-11-16 |
2015-05-21 |
Terumo Bct, Inc. |
Expanding cells in a bioreactor
|
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
WO2016114819A1
(en)
|
2015-01-16 |
2016-07-21 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
AU2015206370A1
(en)
|
2014-01-16 |
2016-07-07 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
WO2015148704A1
(en)
|
2014-03-25 |
2015-10-01 |
Terumo Bct, Inc. |
Passive replacement of media
|
|
CN106415244B
(zh)
|
2014-03-27 |
2020-04-24 |
中央研究院 |
反应性标记化合物及其用途
|
|
US20170107486A1
(en)
|
2014-04-21 |
2017-04-20 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
|
MX375592B
(es)
|
2014-04-25 |
2025-03-06 |
The Children´S Medical Center Corp |
Composiciones y su uso para tratar hemoglobinopatias.
|
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
|
ES2966886T3
(es)
|
2014-05-09 |
2024-04-24 |
Univ Yale |
Partículas recubiertas con poliglicerol hiperramificado y métodos de elaboración y uso de las mismas
|
|
CN106661099A
(zh)
|
2014-05-27 |
2017-05-10 |
中央研究院 |
抗her2醣抗体及其用途
|
|
JP7093612B2
(ja)
|
2014-05-27 |
2022-06-30 |
アカデミア シニカ |
Ｂａｃｔｅｒｏｉｄｅｓ由来のフコシダーゼおよびそれを使用する方法
|
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
|
CA2950415A1
(en)
|
2014-05-27 |
2015-12-03 |
Academia Sinica |
Anti-cd20 glycoantibodies and uses thereof
|
|
WO2015184001A1
(en)
|
2014-05-28 |
2015-12-03 |
Academia Sinica |
Anti-tnf-alpha glycoantibodies and uses thereof
|
|
WO2016011381A1
(en)
*
|
2014-07-18 |
2016-01-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Reducing cxcr4 expression and/or function to enhance engraftment of hematopoietic stem cells
|
|
JP6811706B2
(ja)
|
2014-07-31 |
2021-01-13 |
ザ ホンコン ユニヴァーシティ オブ サイエンス アンド テクノロジー |
Ｅｐｈａ４に対するヒトモノクローナル抗体及びそれらの使用
|
|
TWI745275B
(zh)
|
2014-09-08 |
2021-11-11 |
中央研究院 |
使用醣脂激活人類ｉＮＫＴ細胞
|
|
AU2015314771B2
(en)
|
2014-09-12 |
2021-04-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Wnt signaling agonist molecules
|
|
EP3198006B1
(de)
|
2014-09-26 |
2021-03-24 |
Terumo BCT, Inc. |
Geplante fütterung
|
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
|
JP6779887B2
(ja)
|
2015-01-24 |
2020-11-04 |
アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ |
新規なグリカンコンジュゲートおよびその使用方法
|
|
US20180112180A1
(en)
|
2015-01-26 |
2018-04-26 |
Fate Therapeutics, Inc. |
Cells with increased immuno-regulatory properties and methods for their use and manufacture
|
|
US11572543B2
(en)
|
2015-05-08 |
2023-02-07 |
The Children's Medical Center. Corporation |
Targeting BCL11A enhancer functional regions for fetal hemoglobin reinduction
|
|
US9708412B2
(en)
|
2015-05-21 |
2017-07-18 |
Harpoon Therapeutics, Inc. |
Trispecific binding proteins and methods of use
|
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
|
JP7089282B2
(ja)
|
2015-07-20 |
2022-06-22 |
アンジオクライン・バイオサイエンス・インコーポレイテッド |
幹細胞移植のための方法および組成物
|
|
US20180214487A1
(en)
|
2015-07-21 |
2018-08-02 |
The Children's Medical Center Corporation |
Pd-l1 expressing hematopoietic stem cells and uses
|
|
US11312940B2
(en)
|
2015-08-31 |
2022-04-26 |
University Of Louisville Research Foundation, Inc. |
Progenitor cells and methods for preparing and using the same
|
|
US10935544B2
(en)
|
2015-09-04 |
2021-03-02 |
Obi Pharma, Inc. |
Glycan arrays and method of use
|
|
CA3289997A1
(en)
|
2015-09-20 |
2026-03-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Monoclonal Antibodies Specific for Fibroblast Growth Factor Receptor 4 (FGFR4) and Methods of Their Use
|
|
US11207393B2
(en)
|
2015-10-16 |
2021-12-28 |
President And Fellows Of Harvard College |
Regulatory T cell PD-1 modulation for regulating T cell effector immune responses
|
|
IL261002B2
(en)
|
2016-02-12 |
2024-07-01 |
Bluebird Bio Inc |
Vcn enhancer compositions and methods of using the same
|
|
WO2017139561A1
(en)
|
2016-02-12 |
2017-08-17 |
Bluebird Bio, Inc. |
Vcn enhancer compositions and methods of using the same
|
|
US20200308590A1
(en)
|
2016-02-16 |
2020-10-01 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
|
JP2019508037A
(ja)
|
2016-02-16 |
2019-03-28 |
イェール ユニバーシティーＹａｌｅ Ｕｎｉｖｅｒｓｉｔ |
標的化遺伝子編集を増強するための組成物およびその使用方法
|
|
WO2017147212A1
(en)
|
2016-02-22 |
2017-08-31 |
The Regents Of The University Of California |
Compositions and methods for imaging cell populations
|
|
WO2017152073A1
(en)
|
2016-03-04 |
2017-09-08 |
University Of Louisville Research Foundation, Inc. |
Methods and compositions for ex vivo expansion of very small embryonic-like stem cells (vsels)
|
|
EP3426693A4
(de)
|
2016-03-08 |
2019-11-13 |
Academia Sinica |
Verfahren zur modularen synthese von n-glykanen und anordnungen davon
|
|
WO2017165412A2
(en)
|
2016-03-21 |
2017-09-28 |
Dana-Farber Cancer Institute, Inc. |
T-cell exhaustion state-specific gene expression regulators and uses thereof
|
|
BR112018070097A2
(pt)
|
2016-03-29 |
2019-02-12 |
Obi Pharma, Inc. |
anticorpo, hibridoma, composição farmacêutica, método para tratar câncer em um indivíduo, método para inibir a proliferação de células cancerígenas, método para diagnosticar o câncer em um indivíduo, método para tratar um paciente humano, método para fazer imagens de um indivíduo, conjugado de fármaco-anticorpo (adc), método para tratar câncer, anticorpo biespecífico e método para preparar uma população de anticorpos homogêneos
|
|
WO2017172638A1
(en)
|
2016-03-29 |
2017-10-05 |
Smsbiotech, Inc. |
Compositions and methods for using small mobile stem cells
|
|
US10980894B2
(en)
|
2016-03-29 |
2021-04-20 |
Obi Pharma, Inc. |
Antibodies, pharmaceutical compositions and methods
|
|
KR20230110820A
(ko)
|
2016-04-22 |
2023-07-25 |
오비아이 파머 인코퍼레이티드 |
글로보 계열 항원을 통한 면역 활성화 또는 면역 조정에의한 암 면역요법
|
|
WO2017196847A1
(en)
|
2016-05-10 |
2017-11-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Variable new antigen receptor (vnar) antibodies and antibody conjugates targeting tumor and viral antigens
|
|
US11623958B2
(en)
|
2016-05-20 |
2023-04-11 |
Harpoon Therapeutics, Inc. |
Single chain variable fragment CD3 binding proteins
|
|
EP3493844A4
(de)
|
2016-05-20 |
2021-03-24 |
Harpoon Therapeutics Inc. |
Einzeldomänen-serumalbuminbindendes protein
|
|
WO2017201493A1
(en)
|
2016-05-20 |
2017-11-23 |
Harpoon Therapeutics, Inc. |
Single chain variable fragment cd3 binding proteins
|
|
US11965175B2
(en)
|
2016-05-25 |
2024-04-23 |
Terumo Bct, Inc. |
Cell expansion
|
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
|
WO2017214182A1
(en)
|
2016-06-07 |
2017-12-14 |
The United States Of America. As Represented By The Secretary, Department Of Health & Human Services |
Fully human antibody targeting pdi for cancer immunotherapy
|
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
|
IL290679B2
(en)
|
2016-07-05 |
2023-10-01 |
California Inst Of Techn |
Hybridization chain reaction based on a minimal initiator
|
|
CN110072545A
(zh)
|
2016-07-27 |
2019-07-30 |
台湾浩鼎生技股份有限公司 |
免疫原性/治疗性聚糖组合物及其用途
|
|
US11643456B2
(en)
|
2016-07-29 |
2023-05-09 |
Obi Pharma, Inc. |
Human antibodies, pharmaceutical compositions and methods
|
|
EP3494135A1
(de)
|
2016-08-02 |
2019-06-12 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Gegen glypican-2 (gpc2) gerichtete monoklonale antikörper und verwendung davon
|
|
CA3034057A1
(en)
|
2016-08-22 |
2018-03-01 |
CHO Pharma Inc. |
Antibodies, binding fragments, and methods of use
|
|
CA3034617A1
(en)
|
2016-08-30 |
2018-03-08 |
California Institute Of Technology |
Immunohistochemistry via hybridization chain reaction
|
|
EP3534917B1
(de)
|
2016-10-24 |
2022-08-24 |
United Therapeutics Corporation |
Verbesserung der msc-immunmodulatorischen eigenschaften durch treprostinil
|
|
TWI822055B
(zh)
|
2016-11-21 |
2023-11-11 |
台灣浩鼎生技股份有限公司 |
共軛生物分子、醫藥組成物及方法
|
|
AU2017363300A1
(en)
|
2016-11-23 |
2019-06-20 |
Harpoon Therapeutics, Inc. |
Prostate specific membrane antigen binding protein
|
|
WO2018098356A1
(en)
|
2016-11-23 |
2018-05-31 |
Harpoon Therapeutics, Inc. |
Psma targeting trispecific proteins and methods of use
|
|
EP3548035A4
(de)
|
2016-11-30 |
2020-07-22 |
Case Western Reserve University |
Kombinationen von 15-pgdh-inhibitoren mit corticosteroiden und/oder tnf-inhibitoren und verwendungen davon
|
|
AU2017382883B2
(en)
|
2016-12-21 |
2024-07-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibodies specific for FLT3 and uses thereof
|
|
JP2020514323A
(ja)
|
2017-02-06 |
2020-05-21 |
ケース ウエスタン リザーブ ユニバーシティ |
短鎖デヒドロゲナーゼ活性を調節する組成物と方法
|
|
EP3583203B1
(de)
|
2017-02-15 |
2023-11-01 |
2seventy bio, Inc. |
Spenderreparaturtemplates für multiplex-genomeditierung
|
|
US11535668B2
(en)
|
2017-02-28 |
2022-12-27 |
Harpoon Therapeutics, Inc. |
Inducible monovalent antigen binding protein
|
|
US11261441B2
(en)
|
2017-03-29 |
2022-03-01 |
Bluebird Bio, Inc. |
Vectors and compositions for treating hemoglobinopathies
|
|
CN117247899A
(zh)
|
2017-03-31 |
2023-12-19 |
泰尔茂比司特公司 |
细胞扩增
|
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
|
US12234441B2
(en)
|
2017-03-31 |
2025-02-25 |
Terumo Bct, Inc. |
Cell expansion
|
|
WO2018187493A1
(en)
|
2017-04-04 |
2018-10-11 |
Yale University |
Compositions and methods for in utero delivery
|
|
AU2018261637A1
(en)
|
2017-05-03 |
2019-12-12 |
Biomarin Pharmaceutical Inc. |
Improved lentiviruses for transduction of hematopoietic stem cells.
|
|
EP3621994A4
(de)
|
2017-05-12 |
2020-12-30 |
Harpoon Therapeutics, Inc. |
Mesothelinbindende proteine
|
|
WO2018209304A1
(en)
|
2017-05-12 |
2018-11-15 |
Harpoon Therapeutics, Inc. |
Msln targeting trispecific proteins and methods of use
|
|
WO2018213064A1
(en)
|
2017-05-19 |
2018-11-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Human monoclonal antibody targeting tnfer2 for cancer immunotherapy
|
|
US11788087B2
(en)
|
2017-05-25 |
2023-10-17 |
The Children's Medical Center Corporation |
BCL11A guide delivery
|
|
ES3000510T3
(en)
|
2017-06-09 |
2025-02-28 |
Providence Health & Services Oregon |
Tumor-infiltrating t-cells for use in the treatment of cancer
|
|
WO2019006280A1
(en)
|
2017-06-30 |
2019-01-03 |
Lentigen Technology, Inc. |
HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO CD33 AND METHODS OF USE
|
|
WO2019005208A1
(en)
|
2017-06-30 |
2019-01-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
ANTIBODIES TO HUMAN MESOTHELIN AND USES IN ANTICANCER THERAPY
|
|
US11879137B2
(en)
|
2017-09-22 |
2024-01-23 |
The Children's Medical Center Corporation |
Treatment of type 1 diabetes and autoimmune diseases or disorders
|
|
MX2020003915A
(es)
|
2017-10-13 |
2020-10-08 |
Harpoon Therapeutics Inc |
Proteinas trispecificas y metodos de uso.
|
|
IL315737A
(en)
|
2017-10-13 |
2024-11-01 |
Harpoon Therapeutics Inc |
B-cell maturation antigen-binding proteins
|
|
CN111699003B
(zh)
|
2017-12-19 |
2024-05-03 |
瑟罗泽恩奥普瑞汀公司 |
抗lrp5/6抗体和使用方法
|
|
CN117946267A
(zh)
|
2017-12-19 |
2024-04-30 |
瑟罗泽恩奥普瑞汀公司 |
抗卷曲蛋白抗体和使用方法
|
|
US11773171B2
(en)
|
2017-12-19 |
2023-10-03 |
Surrozen Operating, Inc. |
WNT surrogate molecules and uses thereof
|
|
WO2019213273A1
(en)
|
2018-05-01 |
2019-11-07 |
The Children's Medical Center Corporation |
Enhanced bcl11a rnp / crispr delivery & editing using a 3xnls-cas9
|
|
WO2019213013A1
(en)
|
2018-05-02 |
2019-11-07 |
The Children's Medical Center Corporation |
Improved bcl11a micrornas for treating hemoglobinopathies
|
|
BR112020023330A2
(pt)
|
2018-05-14 |
2021-04-20 |
Harpoon Therapeutics, Inc. |
porção de ligação para ativação condicional de moléculas de imunoglobulina
|
|
TW202504930A
(zh)
|
2018-06-27 |
2025-02-01 |
台灣浩鼎生技股份有限公司 |
用於糖蛋白工程的糖苷合成酶變體及其使用方法
|
|
EP4606428A3
(de)
|
2018-06-27 |
2025-11-05 |
Juvena Therapeutics, Inc. |
Heparin-assoziierte polypeptide und deren verwendungen
|
|
US20210292422A1
(en)
|
2018-07-05 |
2021-09-23 |
Surrozen, Inc. |
Multi-specific wnt surrogate molecules and uses thereof
|
|
US11939377B2
(en)
|
2018-07-12 |
2024-03-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Affinity matured CD22-specific monoclonal antibody and uses thereof
|
|
EP3833684A1
(de)
|
2018-08-08 |
2021-06-16 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Gegen glypican-2 gerichtete, hochaffine monoklonale antikörper und verwendungen davon
|
|
CA3111186A1
(en)
|
2018-08-31 |
2020-03-05 |
Yale University |
Compositions and methods for enhancing triplex and nuclease-based gene editing
|
|
EP3844287B1
(de)
|
2018-08-31 |
2024-05-22 |
Yale University |
Zusammensetzungen und verfahren zur verbesserung der oligonukleotidbasierten geneditierung
|
|
US12195544B2
(en)
|
2018-09-21 |
2025-01-14 |
Harpoon Therapeutics, Inc. |
EGFR binding proteins and methods of use
|
|
US10815311B2
(en)
|
2018-09-25 |
2020-10-27 |
Harpoon Therapeutics, Inc. |
DLL3 binding proteins and methods of use
|
|
JP2022501062A
(ja)
|
2018-10-02 |
2022-01-06 |
イムノーム、インコーポレイテッド |
Ｅｐｎ１を標的とする抗体
|
|
JP7658579B2
(ja)
|
2018-10-19 |
2025-04-08 |
ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム |
操作された長鎖散在反復エレメント（ｌｉｎｅ）トランスポゾンおよびそれらの使用方法
|
|
JP2022513082A
(ja)
|
2018-11-19 |
2022-02-07 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
免疫応答を調節するためのＩＲＥ１α－ＸＢＰ１シグナル伝達経路バイオマーカーの使用
|
|
KR102921276B1
(ko)
|
2018-11-21 |
2026-02-03 |
케이스 웨스턴 리저브 유니버시티 |
단쇄 데히드로게나아제 활성을 조절하는 조성물 및 방법
|
|
WO2020113025A1
(en)
|
2018-11-28 |
2020-06-04 |
Milica Radisic |
Methods for tissue generation
|
|
WO2020112195A1
(en)
|
2018-11-30 |
2020-06-04 |
Yale University |
Compositions, technologies and methods of using plerixafor to enhance gene editing
|
|
CA3125484A1
(en)
|
2019-01-08 |
2020-07-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cross-species single domain antibodies targeting mesothelin for treating solid tumors
|
|
US12122843B2
(en)
|
2019-01-22 |
2024-10-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
High affinity monoclonal antibodies targeting glypican-1 and methods of use
|
|
AU2020275002A1
(en)
|
2019-05-14 |
2021-12-23 |
Harpoon Therapeutics, Inc. |
EpCAM binding proteins and methods of use
|
|
EP3976764B1
(de)
|
2019-05-30 |
2025-07-23 |
Viti, Inc. |
Verfahren zum erkennen einer infektion mit dem mycobakterium tuberculosis
|
|
EP3983542A2
(de)
|
2019-06-17 |
2022-04-20 |
CRISPR Therapeutics AG |
Verfahren und zusammensetzungen für verbesserte homologie-gerichtete reparatur
|
|
WO2020257776A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
|
WO2020257779A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
|
US12496357B2
(en)
|
2019-07-31 |
2025-12-16 |
Yale University |
Compositions and methods for treating sickle cell disease
|
|
WO2021042060A1
(en)
|
2019-08-30 |
2021-03-04 |
Yale University |
Compositions and methods for delivery of nucleic acids to cells
|
|
CA3156761A1
(en)
|
2019-10-22 |
2021-04-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
High affinity nanobodies targeting b7h3 (cd276) for treating multiple solid tumors
|
|
US12297451B1
(en)
|
2019-10-25 |
2025-05-13 |
Regeneron Pharmaceuticals, Inc. |
Cell culture medium
|
|
CN115379850A
(zh)
|
2019-12-24 |
2022-11-22 |
裘美娜治疗公司 |
再生性多肽及其用途
|
|
CN115768463A
(zh)
|
2020-02-21 |
2023-03-07 |
哈普恩治疗公司 |
Flt3结合蛋白及使用方法
|
|
AU2021265768B2
(en)
|
2020-04-27 |
2023-03-30 |
4D Molecular Therapeutics Inc. |
Adeno-associated variants, formulations and methods for pulmonary delivery
|
|
AU2021275122A1
(en)
|
2020-05-20 |
2022-12-15 |
Board Of Regents Of The University Of Texas System |
Compositions and methods of modulating short-chain dehydrogenase activity
|
|
KR20230034299A
(ko)
*
|
2020-07-01 |
2023-03-09 |
네쿠스젠 가부시키가이샤 |
인간 장기 조혈 간세포 마커
|
|
CN116529266A
(zh)
|
2020-08-31 |
2023-08-01 |
耶鲁大学 |
用于将核酸递送到细胞的组合物和方法
|
|
US20230391852A1
(en)
|
2020-10-26 |
2023-12-07 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting sars coronavirus spike protein and uses thereof
|
|
WO2022133246A1
(en)
|
2020-12-17 |
2022-06-23 |
Vertex Pharmaceuticals Incorporated |
Compositions and methods for editing beta-globin for treatment of hemaglobinopathies
|
|
WO2022164796A1
(en)
|
2021-01-26 |
2022-08-04 |
California Institute Of Technology |
Allosteric conditional guide rnas for cell-selective regulation of crispr/cas
|
|
EP4314244B1
(de)
|
2021-03-23 |
2025-07-23 |
Terumo BCT, Inc. |
Zellerfassung und -erweiterung
|
|
WO2022216942A1
(en)
|
2021-04-07 |
2022-10-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for the treatment of cancer
|
|
WO2022232612A1
(en)
|
2021-04-29 |
2022-11-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Lassa virus-specific nanobodies and methods of their use
|
|
US20240277842A1
(en)
|
2021-06-07 |
2024-08-22 |
Providence Health & Services - Oregon |
Cxcr5, pd-1, and icos expressing tumor reactive cd4 t cells and their use
|
|
US20240279687A1
(en)
|
2021-06-07 |
2024-08-22 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|
|
US20240270851A1
(en)
|
2021-06-09 |
2024-08-15 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Cross species single domain antibodies targeting pd-l1 for treating solid tumors
|
|
WO2022271466A1
(en)
|
2021-06-21 |
2022-12-29 |
Juvena Therapeutics, Inc. |
Regenerative polypeptides and uses thereof
|
|
CA3232223A1
(en)
|
2021-09-17 |
2023-03-23 |
Ying Fu |
Synthetic humanized llama nanobody library and use thereof to identify sars-cov-2 neutralizing antibodies
|
|
WO2023076881A1
(en)
|
2021-10-26 |
2023-05-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting the s2 subunit of sars-cov-2 spike protein
|
|
WO2023086969A2
(en)
|
2021-11-12 |
2023-05-19 |
Ichor Medical Systems Inc. |
Treatment methods
|
|
US12209689B2
(en)
|
2022-02-28 |
2025-01-28 |
Terumo Kabushiki Kaisha |
Multiple-tube pinch valve assembly
|
|
CA3262625A1
(en)
|
2022-07-22 |
2024-01-25 |
The Johns Hopkins University |
ADMINISTRATION OF TARGETED INTRACELLULAR CRISPR/CAS SYSTEM ACTIVATED BY DENDRIMER AND GENE EDITING
|
|
USD1099116S1
(en)
|
2022-09-01 |
2025-10-21 |
Terumo Bct, Inc. |
Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device
|
|
US20260070960A1
(en)
|
2022-09-01 |
2026-03-12 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies targeting hpv e6/e7 oncogenic peptide/mhc complexes
|
|
EP4602078A2
(de)
|
2022-10-11 |
2025-08-20 |
Yale University |
Zusammensetzungen und verfahren zur verwendung zellpenetrierender antikörper
|
|
JP2025540052A
(ja)
|
2022-12-01 |
2025-12-11 |
イェール ユニバーシティー |
細胞内ペイロード送達用刺激応答性トレースレス操作プラットフォーム
|
|
WO2024238346A1
(en)
|
2023-05-12 |
2024-11-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Single domain antibodies that specifically bind the s2 subunit of sars-cov-2 spike protein and compositions and uses thereof
|
|
AU2024295016A1
(en)
|
2023-07-20 |
2026-02-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Fully human monoclonal antibodies and chimeric antigen receptors against cd276 for the treatment of solid tumors
|
|
WO2025171238A1
(en)
|
2024-02-07 |
2025-08-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Monoclonal antibodies that bind the juxta-membrane region of mesothelin and uses thereof
|